Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients
about
Adenovirus infections in immunocompetent and immunocompromised patients.Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy.The Impact of Specific Viruses on Clinical Outcome in Children Presenting with Acute Heart Failure.Immune modulation in heart failure: past challenges and future hopes.Pediatric coronary allograft vasculopathy--a review of pathogenesis and risk factors.Viral myocarditis: from experimental models to molecular diagnosis in patients.Viral endomyocardial infection in the 1st year post transplant is associated with persistent inflammation in children who have undergone cardiac transplant.Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression.Adenovirus: current epidemiology and emerging approaches to prevention and treatment.Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting.Adenovirus in solid organ transplantation.Heart transplants in pediatric patients: viral infection as a loss predictor.
P2860
Q34057627-4138BB49-6EEF-4E6F-8D22-226E24758925Q36435963-ED988B89-0574-4632-B8F4-F298DAA6FBD4Q36846996-FCC9CBE3-7482-4DD7-BD5F-31B67E56DD29Q37827408-3F5FA83D-377C-4A8C-AC81-CB5674023ABDQ37969222-8D2D852E-306D-4DA0-B7A6-F3EDC6A4B95DQ38052447-6015C194-7ABB-41A6-B810-E835E8E6F31EQ38107322-023D6F6F-050D-4103-A1CD-583FA9545E7CQ38393265-2BD3A755-90DA-42FD-8B89-03A2447DEF29Q38895571-490C9E72-93A1-4056-B6E1-1820684D0996Q39369050-1016F798-D337-4FAD-94C0-3D0F6B10FEEEQ42211589-6C7A4FAF-10E8-4CD0-A144-E9C7796BEBA4Q42252171-6E1B517F-2D5D-46B4-B1D9-4FD3099EB4EDQ42272305-FBD4B8D1-4FAE-4645-AEC3-6C1E64193BB5Q51773689-26C2E8BD-1DF7-475D-876B-513B13412DFF
P2860
Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Viral endomyocardial infection ...... cardiac transplant recipients
@ast
Viral endomyocardial infection ...... cardiac transplant recipients
@en
Viral endomyocardial infection ...... cardiac transplant recipients
@nl
type
label
Viral endomyocardial infection ...... cardiac transplant recipients
@ast
Viral endomyocardial infection ...... cardiac transplant recipients
@en
Viral endomyocardial infection ...... cardiac transplant recipients
@nl
prefLabel
Viral endomyocardial infection ...... cardiac transplant recipients
@ast
Viral endomyocardial infection ...... cardiac transplant recipients
@en
Viral endomyocardial infection ...... cardiac transplant recipients
@nl
P2093
P2860
P1476
Viral endomyocardial infection ...... cardiac transplant recipients
@en
P2093
Brady S Moffett
Debra L Kearney
E O'Brian Smith
Jack F Price
Jeffrey J Kim
John Lynn Jefferies
John P Breinholt
Joseph W Rossano
Karla R Bowles
Mousumi Moulik
P2860
P304
P356
10.1016/J.JACC.2010.02.060
P407
P577
2010-08-01T00:00:00Z